In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

June 3, 2024

Study Completion Date

June 3, 2024

Conditions
Neuromyelitis Optica
Interventions
PROCEDURE

Blood sampling

The patients will be asked to provide at least 2 peripheral blood samples of approximately 100 milliliters each time, with a minimum of 14 days interval between these 2 samples.If the results obtained with the 2 initial samples would be of interest to the Sponsor, the patient will be asked to come back for additional samplings with a maximum of 6 additional blood draws

Trial Locations (2)

67200

Hôpital de Hautepierre, Strasbourg

69500

Hôpital Pierre Wertheimer, Bron

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Imcyse SA

INDUSTRY

NCT04629274 - In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO | Biotech Hunter | Biotech Hunter